Iron does not bind to the Apo-B protein of low-density lipoprotein

European Journal of Clinical Investigation

Volumn 32, Issue SUPPL. 1, 2002, Pages 17-20

  De Valk, B ^a   Leus, F R ^b   Voorbij, H A M ^b   Marx, J J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Iron; Lipid peroxidation; Low density lipoprotein

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; FERRIC CITRATE; IRON; IRON COMPLEX; LOW DENSITY LIPOPROTEIN; DIAGNOSTIC AGENT;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; DRUG PROTEIN BINDING; INCUBATION TEMPERATURE; IRON BINDING CAPACITY; LIPID PEROXIDATION; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; PROTEIN BINDING; ARTERIOSCLEROSIS; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY;

APOLIPOPROTEINS B; ARTERIOSCLEROSIS; HUMANS; IRON; IRON RADIOISOTOPES; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MOLECULAR WEIGHT;

EID: 18244418277     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.0320s1017.x     Document Type: Article

References (31)

1. Steinberg D, Pathasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
2. Haber F, Weiss J. The catalytic decompensation of hydrogen peroxide by iron salts. Proc Roy Soc Lond 1934;147:332-51.
3. Rice Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993;32:71-110.
4. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993;23 (Suppl. 1):118-26.
5. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994;5:422-33.
6. de Valk B, Marx JJM. Iron, atherosclerosis and ischemic heart disease. Arch Intern Med 1999;159:1542-8.
7. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.
8. Solymoss BC, Marcil M, Gilfix BM, Gelinas F, Poitras AM, Campeau L. The place of ferritin among risk factors associated with coronary artery disease. Coron Artery Dis 1994;5:231-5.
9. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
10. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6.
11. Cartwright GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, et al. Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med 1979;301:175-9.
12. Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994;45:146-9.
13. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
14. Roest M, van der Schouw YT, de Valk B, Marx JJM, Tempelman MJ, de Groot PG, et al. Heterozygosity for the hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-73.
15. Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT, et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation. Circulation 1999;100:1274-9.
16. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994;89:969-74.
17. Tzonou A, Lagiou P, Trichopoulou A, Tsoutsos V, Trichopoulos D. Dietary iron and coronary heart disease risk: a study from Greece. Am J Epidemiol 1998;147:161-6.
18. Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, Boeing H, Hofman A, Witteman JC. Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 1999;149:421-8.
19. Baker E, Morgan EH. Iron transport. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, editors. Iron Metabolism in Health and Disease. London: W.B. Saunders; 1994, pp. 63-95.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
21. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
22. De Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJM. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000;30:248-21.
23. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57:715S-24S.
24. Steinbrecher UP, Zhang HF, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990;9:155-68.
25. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286:901-5.
26. Swain J, Gutteridge JM. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett 1995;368:513-5.
27. Biemond P, Van Eijk HG, Swaak AJG, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanism in inflammatory diseases. J Clin Invest 1984;73:1576-9.
28. Abdalla DS, Campa A, Monteiro HP. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 1992;97:149-59.
29. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986;201:291-5.
30. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: a possible physiological mediator of low density lipoproteinoxidation and endothelial injury. Arterioscler Thromb 1991;11:1700-11.
31. Moura E, Noordermeer MA, Verhoeven N, Verheul AFM, Marx JJM. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 1998;92:2511-19.